clinical trial · NCT07215975
A Real-World Study to Evaluate Luspatercept in Adults With Transfusion-Dependent Beta-Thalassemia in the Middle East
Bristol-Myers Squibb·—·recruiting·n = 200
β-thalassemiaLuspatercept
brief summary
The purpose of this study is to evaluate luspatercept treatment in adults with transfusion-dependent beta-Thalassemia in the Middle East
started
Feb 26, 2026
primary completion
Feb 28, 2030
completion
Apr 17, 2031
last updated
Feb 23, 2026
official title
REal-World Application of Luspatercept in Adults With Transfusion-Dependent Beta-Thalassemia in the Middle East (RELATE): A Non-interventional Retrospective and Prospective Observational Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol